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Water homeostasis in humans is regulated by vasopressin, which induces the translocation of homotetrameric aquaporin-2
(AQP2) water channels from intracellular vesicles to the apical membrane of renal principal cells. For this process, phosphor-
ylation of AQP2 at S256 by cAMP-dependent protein kinase A is thought to be essential. Mutations in the AQP2 gene cause
recessive and dominant nephrogenic diabetes insipidus (NDI), a disease in which the kidney is unable to concentrate urine
in response to vasopressin. Here, a family in which dominant NDI was caused by an exchange of arginine 254 by leucine in
the intracellular C terminus of AQP2 (AQP2-R254L), which destroys the protein kinase A consensus site, was identified.
Expressed in oocytes, AQP2-R254L appeared to be a functional water channel but was impaired in its transport to the cell
surface to the same degree as AQP2-S256A, which mimics nonphosphorylated AQP2. In polarized renal cells, AQP2-R254L
was retained intracellularly and was distributed similarly as AQP2-S256A or wild-type AQP2 in unstimulated cells. Upon
co-expression in MDCK cells, AQP2-R254L interacted with and retained wild-type AQP2 in intracellular vesicles. Further-
more, AQP2-R254L had a low basal phosphorylation level, which was not increased with forskolin, and mimicking consti-
tutive phosphorylation in AQP2-R254L with the S256D mutation shifted its expression to the basolateral and apical mem-
brane. These data indicate that dominant NDI in this family is due to a R254L mutation, resulting in the loss of arginine
vasopressin–mediated phosphorylation of AQP2 at S256, and illustrates the in vivo importance of phosphorylation of AQP2
at S256 for the first time.
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I n hypernatremia or hypovolemia, arginine vasopressin(AVP) release from the pituitary is increased to restore aproper water balance. In renal collecting ducts, AVP will
bind to the vasopressin-2 receptor (AVPR2) located in the ba-
solateral membrane, which will induce a transient increase in
intracellular cAMP, which in turn increases protein kinase A
(PKA) activity. PKA then is thought to phosphorylate several
proteins, including aquaporin-2 (AQP2) water channels, which
reside in intracellular vesicles. Phosphorylated AQP2 (p-AQP2)
then redistributes to the apical membrane, which renders the
cells water permeable. Driven by the transcellular osmotic gra-
dient, water from the glomerular filtrate then enters the cells via
AQP2 and leaves the cells to the interstitium via AQP3 and
AQP4, located in the basolateral membrane, thereby restoring
isotonicity and euvolemia (1,2).
Mutations in the AQP2 gene cause autosomal recessive and
dominant nephrogenic diabetes insipidus (NDI), a disease in
which the kidney is resistant to the action of AVP (3,4). Expres-
sion studies revealed that AQP2 mutants in dominant NDI are
properly folded but are missorted. This sorting defect is also
present in heteroligomers of mutant and wild-type (wt) AQP2,
which explains the dominant negative effect. Depending on
the mutation, however, the mutants in dominant NDI are
missorted to different subcellular destinations (5–10). Data
on the molecular mechanisms underlying dominant NDI
might provide novel cell biologic information on protein
sorting and will broaden our insight on critical elements in
the AQP2 protein.
In this study, we identified a novel mutation in one allele of
a family with dominant NDI, which encodes an AQP2-R254L
mutant protein. For identifying whether AQP2-R254L can be
causal to NDI and for determining the underlying mechanism
of this mutation in dominant NDI in this family, AQP2-R254L
was expressed in oocytes and polarized epithelial MDCK cells
and analyzed in detail.
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Materials and Methods
Analysis of the Patient with NDI
Clinical analyses of inulin and para-amino hippuric acid clearance;
blood and urine osmolalities; and levels of sodium, potassium, urea,
and creatinine were done by standard procedures. The V2R and AQP2
gene of the patient and her mother were sequenced as described (11,12).
Constructs
The constructs encoding pT7Ts-AQP2, pT7Ts-AQP2-R187C, pT7Ts-
AQP2-S256A, pT7Ts-wt-AQP2-F, and G-AQP2 were as described
(3,5,7,13). The cDNA coding for pT7Ts-AQP2-R254L was made by
introducing the mutations into pT7Ts-AQP2 with the Altered Sites
mutagenesis kit (Promega, Madison, WI) using the primer 5-CGAG-
GTGCGACGTCTGCAGTCGGTGG-3. Introduction of only the desired
mutations was confirmed by DNA sequence analysis. For generating
pCB6-AQP2-R254L, the AQP2-R254L coding sequence was digested
from pT7Ts-AQP2-R254L with BglII and SpeI and ligated into the BglII
and XbaI sites of the eukaryotic expression vector pCB6.
For generating a FLAG (DYKDDDDK)-tagged AQP2-R254L expres-
sion construct, pBluescript-FLAG-AQP2 (7) was cut with NotI, blunted
and digested with HindIII, and the FLAG-tagged AQP2 (F-AQP2)
cDNA fragment was isolated. In pCB7, which is similar to pCB6 but
contains a hygromycin instead of neomycin resistance gene, the BamHI
site was cut, blunted, and re-ligated. Next, the F-AQP2 fragment was
ligated into the blunted KpnI site and the HindIII of pCB7-BamHI to
yield pCB7-BamHI-F-AQP2. For generating pCB7-F-AQP2-R254L,
pT7Ts-AQP2-R254L was digested with BamHI and KpnI, a 300-bp
fragment isolated and cloned into the corresponding sites of pCB7-
BamHI-F-AQP2.
Oocytes
The pT7Ts-AQP2 constructs were linearized with SalI. Subsequent
transcription and analysis of the integrity of the obtained cRNA was
done as described (5). cRNA injection of oocytes and analysis of their
water permeabilities were done as reported (3). Statistical significance
was determined using the t test and was considered significant at P 
0.05. Total and plasma membranes were isolated 2 d after cRNA
injection as described (14).
MDCK Cells
MDCK cells were cultured and stably transfected with the expression
constructs as described (15). Selection of G418-resistant clones and
immunocytochemistry of transfected MDCK cells were done as de-
scribed (16). MDCK cell lines that stably expressed wt-AQP2 (wt-10),
AQP2-S256A, or green fluorescent protein (GFP)–tagged AQP2 were as
described (13,17,18).
MAb against FLAG (m2) and early endosomal antigen-1 (EEA1) were
purchased from Sigma (St. Louis, MO), and BD Transduction Labora-
tories (Lexington, KY), respectively. Polyclonal antibodies against the
Golgi marker proteins GOS28 and Giantin and the endoplasmic retic-
ulum (ER) marker protein disulphide isomerase were provided by Dr.
Y. Ikehara (Fukuoka University School of Medicine, Fukuoka, Japan)
and Dr. Ineke Braakman (University of Utrecht, Utrecht, The Nether-
lands). MAb (clone AC17) against the late endosomal/lysosomal
marker protein Lamp2 were provided by Dr. Le Bivic (Marseille,
France). Anti-rabbit and anti-mouse secondary antibodies coupled to
Alexa 488 or 594 were obtained from Molecular Probes (Eugene, OR).
Images were obtained with a Bio-Rad (Hercules, CA) confocal laser-
scanning microscope (CLSM) using a 60 oil-immersion objective and
a three-fold magnification. Orthophosphate labeling of MDCK cells,
immunoprecipitation, and immunoblotting were performed as de-
scribed (18). Transient transfections have been performed using Lipo-
fectAMINE 2000 reagent (Invitrogen Life Technologies, Paisley, UK)
according to the manufacturer’s protocol.
Immunoprecipitation of FLAG-AQP2-R254L Proteins
Binding of monoclonal anti-FLAG antibodies (M2; Sigma) to protein
G–agarose beads (Amersham Pharmacia Biotech AB, Uppsala, Sweden)
was done as described (7). MDCK cells were grown to confluence in
six-wells plates, Well equivalents of cells were scraped in 2 ml of PBS
with 0.02% EDTA, spun down for 5 min at 200  g at 4°C, and
homogenized in HbA (20 mM Tris [pH 7.4], 5 mM MgCl2, 5 mM
NaH2PO4, 1 mM EDTA, 80 mM sucrose, 1 mM PMSF, and 5 g/ml
leupeptin and pepstatin) using a pestle. Unbroken cells and nuclei were
removed by centrifugation for 10 min at 10 g at 4°C. Membranes were
spun down for 1 h at 16,000  g at 4°C. Membranes were solubilized
either in Laemmli buffer (total membranes) or in 1 ml of solubilization
buffer (4% deoxycholate, 20 mM Tris [pH 8.0], 5 mM EDTA, 10%
glycerol, 1 mM PMSF, and 5 g/l leupeptin and pepstatin) and
incubated for 1 h at 37°C. Then the solubilized membranes were rotated
overnight with the protein G beads coupled to anti-FLAG antibodies.
After three washes, the immunoprecipitated proteins were solubilized
in Laemmli buffer and analyzed by immunoblotting.
Densitometric Analysis
For relating the phosphorylation level of AQP2-R254L with that of
wt-AQP2, immunoblot and [32P]orthophosphate signals were semi-
quantified by measuring the integrated optical densities (IOD) of the
film signals using the Image-Pro Plus analysis software (Media Cyber-
netics, Silver Springs, CO). These signals were compared with those of
two-fold dilution series of wt-AQP2, which were blotted, or separated
by SDS-PAGE and autoradiographed, in parallel. Background IOD
values were determined at unexposed areas of the film and subtracted
from obtained IOD values for the different proteins. For determining
the relative levels of phosphorylation, the phosphorylation signals were
normalized for the corresponding amounts of immunoprecipitated
AQP2 and expressed as a percentile of phosphorylated wt-AQP2 pro-
tein detected under unstimulated conditions.
Results
Analyses of the Patient
The proband presented with polyuria and polydipsia within
the first year of life. NDI was diagnosed at the age of 12. At that
time, the patient weighed 48.5 kg, was 150 cm in height, and
had a urinary volume between 4.2 and 7.9 L/24 h, which thus
corresponded to 87 to 163 ml/kg body wt per d. The specific
weight of the urine was in the range of 1003 and 1005 g/L.
Inulin and para-amino hippuric acid clearance were normal.
Upon infusion of 2.5% NaCl, the specific weight and urinary
osmolality increased to 1012 g/L and 452 mOsmol/L, respec-
tively.
The patient then was treated with hydrochlorothiazide, start-
ing with 12.5 mg three times daily and later with 25 mg twice
daily. Under this treatment, water intake was approximately
1.5 and 3 L/24 h, and the specific weight of the urine raised to
1018 g/L. The father of the index patient, who has passed away,
also had a history of polydipsia and polyuria and low urinary
osmolality of 182 mOsmol/L. Upon administration of vaso-
pressin, his UOsm increased only slightly (241 mOsmol/L). The
mother was not affected.
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The male patient is now 51 yr of age and has mental retar-
dation, most likely as a result of recurrent hypernatremic epi-
sodes, and has type 2 diabetes. He is treated with hydrochlo-
rothiazide (25 mg twice daily) and supplemented with
potassium. His current water intake amounts 5 to 6 L/24 h,
which corresponds to 55 to 65 ml/kg body wt per day.
Because mutations in the X-linked AVPR2 gene are the most
common cause of congenital NDI, its coding sequence in the
proband was determined. However, no mutation was found.
Subsequent genomic analysis of the AQP2 gene of the proband
revealed a mutation in one allele (G761T), which leads to an
AQP2 protein in which Arg254 is exchanged for a Leu (AQP2-
R254L). This mutation was not observed in the AQP2 gene of
80 healthy individuals. The AQP2 genes of the mother re-
vealed no mutation (Figure 1).
Functional Analysis of AQP2-R254L in Oocytes
For determining whether the identified missense mutation
could be the underlying cause for NDI in this family, the
mutation was introduced into the AQP2 cDNA sequence,
cloned into an oocyte expression vector, and transcribed. Be-
cause R254 in AQP2 is part of the PKA phosphorylation con-
sensus site (R-R254-X-S), we hypothesized that the R254L mu-
tation in AQP2 might interfere with proper phosphorylation of
S256 and plasma membrane expression of the protein, as
AQP2-S256A, which mimics nonphosphorylated AQP2, is re-
tained in vesicles in oocytes and in mammalian cells (18–21).
Subsequently, oocytes were injected with different amounts
of cRNA encoding wt-AQP2 or with 0.3 ng of cRNA encoding
either AQP2-R254L or AQP2-S256A. Determination of the wa-
ter permeabilities (Pf) revealed that AQP2-R254L is a functional
water channel, because the Pf of oocytes that expressed AQP2-
R254L (22.8  6.8; n  8) was significantly higher than those of
controls (8.9  4.9; n  8; P  0.005; Figure 2A). To determine
whether the reduced Pf of AQP2-R254L-expressing oocytes was
due to an impaired transport of AQP2-R254L to the plasma
membrane, we isolated total membranes and plasma mem-
branes from the same batches of oocytes. Subsequent AQP2
immunoblotting revealed that the total expression of AQP2-
R254L was in between that of oocytes that were injected with
0.1 and 0.3 ng of wt-AQP2 cRNA (Figure 2B, TM) but that its
plasma membrane expression level was less than that of oo-
cytes injected with 0.1 ng of wt-AQP2 cRNA (Figure 2B, PM).
These data indicated that AQP2-R254L was impaired in its
trafficking to the plasma membrane and thus that the R254L
mutation was likely to cause NDI in this family. It is interesting
that the total and plasma membrane expression as well as the Pf
of AQP2-R254L and AQP2-S256A were similar, which indi-
cated that the molecular cause for AQP2-R254L in dominant
NDI indeed could be the lack of S256 phosphorylation. As
shown for AQP2-S256A (5,20), functional AQP2 mutants in
recessive NDI (13,22,23), a retained AQP2 mutant in dominant
NDI (AQP2-E258K [7,22]), and also here for wt-AQP2 (Figure
2), the conferred water permeability for AQP2-R25L was re-
lated directly to its expression level (Figure 2C).
AQP2-R254L Heteroligomerizes with wt-AQP2
AQP2 mutants in dominant but not recessive NDI are able to
exit the ER and exert their dominant negative effect by forming
heteroligomers with wt-AQP2 (6–8,10). For determining
whether AQP2-R254L forms heteroligomers with wt-AQP2,
membranes of oocytes that expressed FLAG-tagged wt-AQP2
(F-AQP2) alone or in combination with wt-AQP2, AQP2-R254L,
or AQP2-R187C (a mutant in recessive NDI) were solubilized
and subjected to immunoprecipitation using FLAG antibodies.
Immunoblotting of total membranes for AQP2 revealed a
31-kD band representing F-AQP2; a 29-kD band corresponding
to untagged wt-AQP2, AQP2-R254L, and AQP2-R187C; and a
32-kD band corresponding to high-mannose glycosylated
AQP2-R187C (Figure 2D, TM). Immunoblot analysis of the
immunoprecipitates revealed that wt-AQP2 and AQP2-R254L
co-precipitated with F-AQP2 (Figure 2D, IP). As reported (7),
AQP2-R187C did not oligomerize with wt-AQP2. No AQP2
was detected in the immunoprecipitates from oocytes that ex-
pressed AQP2 only, which showed the specificity of the immu-
noprecipitations for FLAG-tagged proteins. From these results,
it was concluded that AQP2-R254L forms heteroligomers with
wt-AQP2.
Localization and Translocation of AQP2-R254L in
MDCK Cells
As oocytes are not polarized (as collecting duct cells) and we
were not able to study AQP2 phosphorylation in these cells,
polarized MDCK cells were transfected with a eukaryotic ex-
pression construct encoding AQP2-R254L. MDCK cells do not
endogenously express AQP2, but MDCK cells that stably ex-
press human AQP2 (MDCK-AQP2 cells) show a proper regu-
lation of AQP2 translocation by forskolin and AVP (17). Single
MDCK-AQP2-R254L clones were grown to confluence, incu-
bated with or without forskolin, and subjected to AQP2 immu-
Figure 1. Inheritance of nephrogenic diabetes insipidus (NDI) in
the studied family. Healthy (open symbols) and affected indi-
viduals (closed symbols), male (squares) or female (circles)
individuals, and the aquaporin 2 (AQP2) mutation or normal
(n) allele are indicated. A slashed symbol indicates a deceased
individual.
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nocytochemistry. CLSM revealed that AQP2-R254L localized to
intracellular vesicles, which was not changed upon incubation
with forskolin (Figure 3, top). In contrast, forskolin treatment of
MDCK-AQP2 cells resulted in the translocation of wt-AQP2
from intracellular vesicles to the apical membrane (Figure 3,
bottom). It is interesting that in unstimulatedMDCK-AQP2 and
MDCK-AQP2-R254L cells, the distribution of AQP2 seemed
similar to that found for AQP2-S256A (18). Therefore, for iden-
tifying the subcellular organelles in which AQP2-R254L re-
sides, MDCK cells that expressed wt-AQP2, AQP2-R254L, or
AQP2-S256A were tested for co-localization with marker pro-
teins for the ER (protein disulphide isomerase), cis-Golgi
(GOS28), medial-trans-Golgi (Giantin), early endosomes
(EEA1), or late endosomes/lysosomes (Lamp2). However, none
of the studied AQP2 proteins seemed to co-localize with the
marker proteins (data not shown), except for EEA1, which
partially co-localized with all three proteins (Figure 4A,
arrows).
AQP2-R254L Impairs Trafficking of wt-AQP2 to
Apical Membrane
Because AQP2-R254L was retained in intracellular vesicles in
MDCK cells, we next wanted to investigate whether AQP2-
R254L exhibits a dominant negative effect on the trafficking of
GFP-tagged AQP2 (G-AQP2). For obtaining cells that express
G-AQP2 alone as well as together with FLAG-tagged AQP2-
R254L (F-AQP2-R254L), F-AQP2-R254L was transiently ex-
pressed in MDCK cells that stably expressed G-AQP2. Immu-
nocytochemistry and CLSM analysis of monolayers revealed
that in cells that co-expressed G-AQP2 and AQP2-R254L, the
Figure 2. Functional analysis and expression of AQP2-R254L in
oocytes. The x axis of A also applies for B. (A) Water perme-
ability in oocytes. Three days after injection of the indicated
amounts of wild-type (wt)-AQP2, AQP2-R254L, or AQP2-
S256A cRNA (in ng), oocytes were subjected to a standard
swelling assay. Noninjected oocytes were taken as a control (c).
Mean water permeabilities (Pf) and SEM of eight oocytes are
shown. Significant differences in water permeability compared
with control oocytes are indicated by asterisks. (B) AQP2 ex-
pression in oocytes. From 12 oocytes injected as described
above, total membranes (TM) or plasma membranes (PM) were
isolated. Subsequently, equivalents of one (TM) or four (PM)
oocytes were immunoblotted for AQP2. Molecular masses (in
kD) are indicated on the right. (C) Relation between AQP2-
R254L expression and water permeability. Of oocytes that were
injected with different amounts of AQP2-R254L cRNA (indi-
cated; in ng) or noninjected oocytes (c), the water permeability
(Pf) was measured, and the expression in TM was determined
as described above. (D) Heteroligomerization of AQP2-R254L
with wt-AQP2. Of 30 oocytes, expressing AQP2 alone or a
combination of F-AQP2 with wt-AQP2, AQP2-R254L, or AQP2-
R187C, TM were isolated. Equivalent fractions were solubilized
in deoxycholate and subjected to immunoprecipitation (IP)
using anti-FLAG antibodies. Subsequently, TM and IP were
immunoblotted for AQP2. The molecular masses of high-man-
nose glycosylated AQP2 (32), unglycosylated (29) AQP2, and
FLAG-tagged AQP2 (31) are indicated in kD on the right.
Figure 3. Localization of wt-AQP2 and AQP2-R254L in MDCK
cells. MDCK cell lines that stably expressed AQP2-R254L or
wt-AQP2 (indicated) were grown to confluence on semiperme-
able filters and incubated overnight with indomethacin to re-
duce basal cAMP levels (unstimulated; left). Subsequently, cells
were stimulated for 45 min with forskolin in the presence of
indomethacin (forskolin; right). After fixation and permeabili-
zation, the cells were incubated with rabbit anti-AQP2 antibod-
ies, followed by Alexa 488–conjugated anti-rabbit antibodies,
and analyzed by confocal laser scanning microscopy (CLSM).
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proteins co-localized in intracellular vesicles (Figure 4B; arrow).
In contrast and as reported before (13), cells that expressed only
G-AQP2 showed a dispersed expression pattern, which is typ-
ical for apical membrane expression (Figure 4B, asterisks). For
revealing the heteromeric AQP2 interaction biochemically, cells
that stably expressed either G-AQP2 or G-AQP2 and F-AQP2-
R254L were subjected to immunoprecipitations using anti-
FLAG antibodies. Immunoblot analysis of the immunoprecipi-
tates with GFP antibodies showed that G-AQP2 co-precipitated
with F-AQP2-R254L (Figure 4C, IP), whereas the cells that
expressed G-AQP2 only do not show any signal. These data
revealed that AQP2-R254L interacts with and impairs the traf-
ficking of wt-AQP2 to the apical membrane.
Phosphorylation of AQP2-R254L in MDCK Cells
For testing whether the retention of AQP2-R254L in MDCK
cells is due to a lack of S256 phosphorylation, MDCK cells that
expressed wt-AQP2, AQP2-R254L, or AQP2-S256A were sub-
jected to orthophosphate labeling in the presence or absence of
forskolin. Indomethacin was used in all samples to reduce
intracellular cAMP levels and basal AQP2 phosphorylation
(17). Subsequently, AQP2 proteins were immunoprecipitated,
and equivalents were loaded on a gel and exposed to a film for
3 d (Figure 5A, 32P) or immunoblotted for AQP2 (Figure 5A,
IB). Analysis of the autoradiogram revealed that wt-AQP2 and
AQP2-R254L are already phosphorylated in the absence of
forskolin stimulation. In contrast, AQP2-S256A was not phos-
phorylated, even though these cells were stimulated with for-
skolin and AQP2-S256A was expressed at high levels.
Upon stimulation with forskolin, no increase in the level of
phosphorylation was observed for AQP2-R254L, in contrast to
wt-AQP2. Densitometric scanning of the [32P] signals and nor-
malization for AQP2 expression levels (Figure 5A, IB) revealed
that with or without stimulation, the level of AQP2-R254L
phosphorylation was only approximately 2% of that of un-
stimulated wt-AQP2 and that forskolin increased wt-AQP2
phosphorylation 2.5-fold (Figure 5B).
These results indicated that the lack of phosphorylation at
S256 by PKA might be the molecular reason for the impaired
translocation of AQP2-R254L to the plasma membrane. Previ-
ously, we showed that AQP2-S256D mimics constitutively
phosphorylated AQP2, as this protein even localizes in the
apical membrane of MDCK cells without forskolin treatment
(18,20). For determining whether the lack of phosphorylation
was the only reason for AQP2-R254L to be involved in NDI, the
S256D mutation was introduced into AQP2-R254L and tran-
siently expressed in MDCK cells. CLSM analysis consistently
revealed that AQP2-R254L-S256D was localized in the basolat-
eral and apical membrane, besides some remaining vesicular
expression (Figure 6). This localization was not influenced by
forskolin treatment (data not shown).
Discussion
Lack of S256 Phosphorylation Likely Is the Molecular Cause
of Dominant NDI Caused by AQP2-R254L
Here, we identified a novel mutation in the AQP2 gene of a
patient with dominant NDI. Our data indicate that, similar to
other AQP2 mutants in dominant NDI (5–8,10), the encoded
AQP2-R254L mutant protein causes dominant NDI by inhibit-
ing the trafficking of wt-AQP2 to the apical membrane of the
Figure 4. (A) Localization of AQP2-R254L to early endosomes.
MDCK cells stably expressing wt-AQP2, AQP2-R254L, or
AQP2-S256A were grown and treated as unstimulated cells
described in the legend of Figure 3. Next, the cells were fixed,
permeabilized, and immunostained for AQP2 and early endo-
somal antigen-1 (EEA1) and subjected to CLSM analysis. Co-
localization of EEA1 (red) and AQP2 (green) are indicated by
arrows. (B) AQP2-R254L impairs sorting of wt-AQP2 to the
apical membrane. MDCK cells that stably expressed green flu-
orescent protein (GFP)–tagged wt-AQP2 (GFP-AQP2) were
transiently transfected with a FLAG-tagged AQP2-R254L
(F-AQP2-R254L) expression construct and grown and treated
as described in the legend of Figure 3. After fixation and
permeabilization, cells were immunostained with FLAG anti-
bodies and analyzed by CLSM. Upon co-expression, G-AQP2
(green) and F-AQP2-R254L (red) co-localize in intracellular ves-
icles (arrows), whereas G-AQP2 alone is expressed in the apical
membrane (*). (C) F-AQP2-R254L heteroligomerizes with G-
AQP2 in MDCK cells. Solubilized membranes from cells ex-
pressing G-AQP2 alone or F-AQP2-R254L and G-AQP2 were
isolated and split into two equivalent fractions. After solubili-
zation and immunoprecipitation with FLAG antibodies, both
the lysates and IP samples were immunoblotted for AQP2. The
masses of G-AQP2 and F-AQP2-R254L are indicated in kDa on
the right.
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principal cells of the patient, because of the following: Upon
expression in oocytes and MDCK cells, AQP2-R254L was a
functional water channel but was retained in the cell. However,
it was not retained in the ER, as a 32-kD high-mannose glyco-
sylation band, which is characteristic for ER-retained AQP2
mutants in recessive NDI (13,24,25), was not observed (Figure
2). Also, AQP2-R254L formed heteroligomers with wt-AQP2 in
oocytes (Figure 2) and MDCK cells (Figure 4C) and impaired
the further trafficking of wt-AQP2 to the plasma membrane
(Figure 4B).
Our data also indicate that the lack of phosphorylation of
AQP2-R254L at S256 is the major, if not only, molecular cause
of NDI in this family. At first, AQP2-R254L was retained to a
similar extent and gave similar water permeability in oocytes as
AQP2-S256A (Figure 2). In addition, AQP2-R254L, AQP2-
S256A, and unstimulated wt-AQP2 (the majority of wt-AQP2 is
unphosphorylated) seemed to localize to the same compart-
ments in MDCK cells, as they all partially co-localized with
EEA1, an endosomal marker protein (Figure 4A), whereas none
of them localized to the ER, cis-median Golgi complex, trans-
Golgi network, late endosomes/lysosomes, or basolateral
membrane (data not shown). Most convincing, however, fors-
kolin treatment did not increase phosphorylation of AQP2-
R254L or AQP2-S256A, in contrast to wt-AQP2 (Figure 5, A and
B), and introduction of “constitutive phosphorylation,” as real-
ized with AQP2-R254L-S256D, clearly shifted its expression
from intracellular vesicles to the plasma membrane (Figure 6).
Although the osmolality of 452 obtained after saline infusion
should be interpreted with caution because we did not measure
the volume of saline infused, the concomitant increase in
plasma sodium, or the NaK content of the urine, infusion
with hypertonic saline and hydrochlorothiazide seemed to im-
prove the urine-concentrating ability of the proband. In lithi-
um-NDI rats, hydrochlorothiazide seemed to improve the
urine-concentrating ability, which coincided with increased
AQP2 expression levels (26). If hydrochlorothiazide also in-
creases AQP2 expression in humans, then this might indicate
that NDI caused by retention of wt-AQP2 as a result of its
interaction with AQP2-R254L might be partially overcome by
an increased expression, as a higher level of AQP2-R254L
expression resulted in a higher level of water permeability
(Figure 2).
Using antibodies that recognize p-AQP2, it has been shown
that AQP2 is phosphorylated at S256 in vivo (27,28) and that
phosphorylation of AQP2 at S256 is essential for its trafficking
to the plasma membrane in vitro (18–21). Because AQP2-R254L
is impaired in its phosphorylation of S256 and causes dominant
NDI, it reveals for the first time the fundamental importance of
AQP2 phosphorylation at S256 in vivo.
Figure 5. (A) Phosphorylation of AQP2-R254L in MDCK cells.
Cells expressing wt-AQP2, AQP2-R254L, or AQP2-S256A were
grown, and triplicates from each cell line were treated with
indomethacin (I) or indomethacin/forskolin (IF), as described
in the legend of Figure 3, and subjected to [32P]orthophosphate
labeling. After cell lysis, the AQP2 proteins were immunopre-
cipitated, split into two portions, one of which was separated
on SDS-PAGE and autoradiographed (32P), whereas the second
was immunoblotted for AQP2 (IB). (B) Semiquantification of
the level of AQP2-R254L phosphorylation. The [32P] and im-
munoblot signals of AQP2 in A were densitometrically scanned
and normalized against the AQP2 protein expression levels.
Bars represent the ratio of phosphorylated AQP2 normalized
for the total amount of that particular AQP2. The level of
phosphorylation as found for wt-AQP2 incubated with indo-
methacin was set to 100%.
Figure 6. AQP2-R254L-S256D expression in MDCK cells. Polar-
ized MDCK cells that transiently expressed AQP2-R254L-
S256D were incubated in normal medium, fixed, immuno-
stained for AQP2 proteins, and subjected to CLSM analysis as
described in the legend of Figure 4A. Independent of forskolin
treatment, AQP2-R254L-S256D was localized mainly in the api-
cal and basolateral membrane, whereas some was retained in
intracellular vesicles.
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The Kinase That Phosphorylates S256 in AQP2
Because S256 is part of a cAMP-dependent PKA phosphory-
lation consensus site [(R/K)2-X-S/T] and AVP in collecting
ducts is known to induce a cAMP signaling cascade, it is widely
assumed that AQP2 is phosphorylated by PKA. However, the
necessity for cytosolic calcium and activated calmodulin in
AVP-induced AQP2 translocation to the plasma membrane of
primary collecting duct cells (29) suggests that AQP2 might
also be phosphorylated by the calcium-sensitive calmodulin
kinase II (CaMKII), which is expressed in renal principal cells
(30) and the consensus site (R-X-X-X-S/T-X [31]) of which also
fits the Ser256 region. In addition, the Ser256 region conforms
to the consensus site for cGMP-dependent protein kinase G
[PKG; (R/K)2-3-X-S/T-X (31)], and Bouley et al. (32) recently
reported that nitric oxide and atrial natriuretic factor stimulate
cGMP-dependent phosphorylation and plasma membrane in-
sertion of AQP2 in kidney slices and cultured LLCPK1-AQP2
cells.
Our study provides further evidence that PKA indeed medi-
ates the AVP-mediated phosphorylation of AQP2. Because for-
skolin increases the levels of cAMP in MDCK-AQP2 cells (17)
but not of calcium (data not shown) and the R254L mutation
destroys the PKA consensus site but not those of CaMKII or
PKG, the forskolin-induced phosphorylation of wt-AQP2 but
not of AQP2-R254L indicates that wt-AQP2 phosphorylation by
AVP is mediated via PKA. However, the basal level of phos-
phorylation of AQP2-R254L, in which the PKA consensus site
thus is destroyed, indicates that other kinases also can phos-
phorylate AQP2. Although other putative sites in AQP2-R254L
can not be excluded, the site phosphorylated in AQP2-R254L
most likely is S256 for the following reasons. First, in the same
orthophosphate labeling experiment (Figure 5), AQP2-S256A
was not phosphorylated by forskolin, but its expression level
was higher than that of wt-AQP2 or AQP2-R254L. Second, of all
of the putative Ser/Thr phosphorylation sites in AQP2, only
S256 seemed to have a role in AQP2 trafficking and forskolin-
induced translocation of AQP2 to the plasma membrane
(18–21). Third, treatment with the protein kinase C activator
4-12-O-tetradecanoylphorbol-13-acetate in combination with
forskolin induced the internalization of phosphorylated wt-
AQP2 as well as AQP2-S256D. Using orthophosphate labeling
assays and antibodies that recognize S256 phosphorylation,
however, phosphorylation of a site other than S256 was never
detected (18).
Although PKG (and other unknown kinases) cannot be ex-
cluded, the basal level of phosphorylation of AQP2-R254L
might be mediated by CaMKII, as its consensus site is still intact
in AQP2-R254L and the presence of calcium is also essential for
AQP2 translocation in MDCK cells (F. Detmers and P.D., un-
published data). It remains to be determined, however,
whether wt-AQP2 is phosphorylated at a basal level by other
kinases and, if so, whether this has a physiologic role in the
regulation of AQP2.
Basolateral Targeting of Phosphorylated AQP2-R254L
Epithelial cells have distinct apical and basolateral mem-
branes with different protein compositions. This asymmetry is
critical for their function and results from sorting mechanisms
that recognize specific sorting signals. Basolateral signals in-
clude tyrosine motifs (NPXY or YXXØ), as well as dileucine and
dihydrophobic residues (33,34). The R254L mutation, however,
does not introduce a dileucine or dihydrophobic motif, as po-
sition 254 is flanked by an arginine and a glutamine. However,
recent reports indicate that a single leucine can also mediate
basolateral sorting, as the basolateral expression of the stem cell
factor and CD147 also depend on the presence of a single
leucine residue in their C-terminal tails (35,36). In addition,
another AQP2 mutant in dominant NDI (AQP2-insA) was tar-
geted to the basolateral membrane because of two newly intro-
duced basolateral sorting signals in the AQP2 C-terminus.
These signals included a monoleucine at L259, which by itself
was sufficient for a complete basolateral expression of the
AQP2 mutant (6). Because AQP2-S256D is expressed only in the
apical membrane (18) and the apical sorting information of
AQP2 is contained in the proximal region of its C tail (37), the
even distribution of AQP2-R254L-S256D over the apical and
basolateral membrane (Figure 6) indicates that the basolateral
sorting signal formed by L254 in AQP2-R254L is weaker than
L259 in AQP2-insA to overrule the apical sorting signal(s) in
AQP2, which might contribute to the partial ability of the
patient to concentrate urine with hypertonic saline and thia-
zide. Similarly, the retention of the AQP2-P262L mutant in
intracellular vesicles was overcome by co-expression of and
interaction with wt-AQP2, which explained the involvement of
AQP2-P262L in recessive instead of dominant NDI (38). These
data indicate that the severity of NDI in patients with dominant
NDI depends to great extent on the strength by which an AQP2
mutant protein is able to prevent trafficking of wt-AQP2/
mutant heteromeric complexes to the apical membrane and
suggests that a single copy of some mutations in AQP2 may
contribute to individual variation in ability to concentrate
urine.
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